NGFR and melanoma: Similar data were reported by Cheli et al., who distinguished between fast growing CD271+ without tumorigenic potential and slow growing CD271+ with the ability to form tumors in mice35, indicating that CD271 is an imperfect marker of melanoma initiating cells.